ALGN earnings

Record Q1'26 Invisalign® Clear Aligner shipments of 685.7 thousand increased 6.7% year-over-year reflecting double-digit growth in the EMEA, APAC, and LATAM regions, and stability in North America Q1'26 Clear Aligner shipments to Orthodontists and GP Dentists increased 7.4% and 5.6% year-over-year, respectively Q1'26 Invisalign teen/kid patients increased 4.8% year-over-year and Invisalign adult patients increased 7.8% year-over-year Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year Q1'26 total revenues were favorably impacted by foreign exchange by approximately $8.7 million sequentially, and favorably impacted by approximately $44.9 mi

Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2026 financial results on Wednesday, April 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

Q4'25 record total revenues of $1,047.6 million, up 5.2% sequentially and up 5.3% year-over-year. Q4'25 Systems and Services revenues up 10.3% sequentially, and up 4.2% year-over-year, reflecting continued iTero Lumina™ upgrades and higher volume across all regions, and higher services revenues. Q4'25 Clear Aligner revenues up 4.0% sequentially and up 5.5% year-over-year. Q4'25 record Clear Aligner volumes of 676.9 thousand cases, up 4.5% sequentially, and up 7.7% year-over-year, driven by strength in the EMEA, Latin America and Asia Pacific regions and stability in North America. Q4'25 Clear Aligner volumes up 8.9% year-over-year in the Orthodontic channel, and up 5.3% year-over-year in

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The confere

Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our guidance Q3'25 Clear Aligner volume increased 4.9% year-over-year reflecting strength internationally, and increased 0.5% sequentially reflecting strength from teens and kids Q3'25 Clear Aligner volume for teens and kids increased 8.3% year-over-year and 14.7% sequentially, driven by increased doctor submitters and continued adoption of Invisalign First™ Q3'25 total revenues were $995.7 million, up 1.8% year-over-year and down 1.7% sequentially, as expected, and above our Q3'25 outlook range of $965 million to $985 million Q3'25 total revenues were favorably impa

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b

Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non

Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year 2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million 2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1) 2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GA

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2024 financial results on Wednesday, February 5, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call w

Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55, or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by foreign exchange by approximately $14.6 million year-over-year(1), and were not significantly impacted sequentially Q3'24 operating income of $162.3 million and operating margin of 16.6%, non-GAAP operating margin of 22.1% Q3'24 GAAP operating margin was unfavorably impacted by foreign exchange by approximately 0.8 points year-over-year(1), and was not significantly impacted sequentially

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2024 financial results on Wednesday, July 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2024 financial results on Wednesday, April 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will beg

Unveils Next-Generation iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture1 in a 50% Smaller Wand2 that Delivers Faster Scanning, Higher Accuracy3, and Superior Visualization4 for Greater Practice Efficiency Q4 and FY2023 total revenues up 6.1% year over year and up 3.4% year over year, respectively Major 2023 milestones: 17 million Invisalign® patients, 4 million Vivera™ retainers, and 100 thousand iTero™ scanner units 2023 total revenues of $3.9 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $662.9 million 2023 revenues were unfavorably impacted by foreign exchange of approximately $36.3 million compared to 2022(5) 2023

Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call

Q3'23 record clear aligner shipments to teenage patients increased 9.9% sequentially and 8.4% year over year, driven by continued strength from Invisalign First™ Company expects to repurchase up to $250.0 million of its common stock in Q4'23 Q3'23 total revenues of $960.2 million, increased 7.8% year-over-year, and diluted net income per share of $1.58, non-GAAP diluted net income per share of $2.14 Q3'23 revenues were unfavorably impacted by foreign exchange of approximately $2.7 million sequentially and favorably impacted by approximately $4.2 million year-over-year(1) Q3'23 operating income of $166.3 million and operating margin of 17.3%, non-GAAP operating margin of 21.8%

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2023 financial results on Wednesday, October 25, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b

Better than expected revenues and operating margins reflect improving trends across regions Q2'23 Clear Aligner cases for teenagers increased 7% sequentially and 10% year over year, driven by momentum in both Submitters and Utilization and continued growth from Invisalign First™ Q2'23 total revenues of $1.0 billion, increased 6.3% sequentially and 3.4% year-over-year, and diluted net income per share of $1.46, non-GAAP diluted net income per share of $2.22 Q2'23 revenues were favorably impacted by foreign exchange of approximately $1.3 million sequentially and unfavorably impacted by approximately $19.4 million year-over-year(1) Q2'23 operating income of $171.9 million and operat

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2023 financial results on Wednesday, July 26, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will beg

Delivers revenue and EPS ahead of expectations, with total Invisalign® patients treated surpassing 15 million globally Completes May 13, 2021 $1 Billion Stock Repurchase Program Q1'23 total revenues of $943.1 million, increased 4.6% sequentially, and diluted net income per share of $1.14, non-GAAP diluted net income per share of $1.82 Q1'23 revenues were favorably impacted by foreign exchange of approximately $25.8 million sequentially and unfavorably impacted by approximately $34.9 million year over year(1) Q1'23 operating income of $133.5 million and operating margin of 14.2%, non-GAAP operating margin of 18.5% Q1'23 GAAP operating margin was favorably impacted by foreign ex

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2023 financial results on Wednesday, April 26, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

Q4 total revenues of $901.5 million and 2022 total revenues of $3.7 billion Board of Directors has authorized a new $1 billion stock repurchase program, to succeed the current $1 billion program that is expected to be completed in Q2 2023  2022 total revenues of $3.7 billion, Clear Aligner revenues of $3.1 billion and Systems and Services revenues of $662.1 million 2022 revenues were unfavorably impacted by foreign exchange of approximately $193.8 million(1) compared to 2021 2022 operating margin of 17.2%, non-GAAP operating margin of 21.5%, and diluted net income per share of $4.61, non-GAAP diluted net income per share of $7.76(3) 2022 operating margin was unfavorably impacted by

Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2022 financial results on Wednesday, February 1, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call w

Company delivering on innovation roadmap; expanding geographically with first EMEA manufacturing facility; and celebrating 14 millionth Invisalign patient milestone Q3'22 total revenues of $890.3 million, and diluted net income per share of $0.93 Q3'22 revenues were unfavorably impacted by foreign exchange of approximately $25.1 million sequentially and approximately $57.4 million year over year (1) Q3'22 operating income of $143.7 million and operating margin of 16.1% Q3'22 operating margin was unfavorably impacted by foreign exchange of approximately 1.6 points sequentially and approximately 3.5 points year over year (1) Q3'22 Clear Aligner revenues of $732.8 million and Cle

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2022 financial results on Wednesday, October 26, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

Company operating well through unprecedented global economic headwinds and continued impacts of COVID-19 variants in certain markets Q2'22 total revenues of $969.6 million were down slightly sequentially and year over year Q2'22 revenues were unfavorably impacted by foreign exchange of approximately $15.3 million sequentially and approximately $39.9 million year over year (1) Q2'22 operating income of $188.2 million and operating margin of 19.4%, which was unfavorably impacted by foreign exchange of approximately 1.1 points sequentially and approximately 2.4 points year over year (1) Q2'22 diluted net income per share of $1.44; Q2'22 non-GAAP diluted net income per share of $2.00

Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2022 financial results on Wednesday, July 27, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begi

Q1'22 total revenues of $973.2 million, compared to $894.8 million in Q1'21Q1'22 Invisalign volume of 598.8 thousand cases, compared to 595.8 thousand cases in Q1'21Q1'22 Invisalign cases for teenage patients of 175.2 thousand cases, 29.3% of total volumes, compared to 165.3 thousand cases, or 27.7% of total volumes in Q1'21Q1'22 Clear Aligner revenues of $809.7 million, compared to $753.3 million in Q1'21Q1'22 Imaging Systems and CAD/CAM Services revenues of $163.5 million, compared to $141.5 million in Q1'21Q1'22 diluted net income per share of $1.70; Q1 non-GAAP diluted net income per share of $2.13 TEMPE, Ariz., April 27, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALG

TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2022 financial results on Wednesday, April 27, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its f

2021 total revenues up 59.9% to a record $4.0 billion, operating margin of 24.7%, in line with guidance2021 revenue growth for the second half was 30.5% compared to 2020, at high-end of 20% to 30% target, in line with guidance2021 Clear Aligner revenues up 54.5% to a record $3.2 billion, compared to 20202021 Imaging Systems and CAD/CAM Services revenues up 90.4% to a record $705.5 million, compared to 2020Q4 total revenues up 23.6% year-over-year to a record $1.03 billionQ4 operating income up 3.6% year-over-year to $220.9 million and operating margin of 21.4%Q4 diluted net income per share of $2.40; Q4 non-GAAP diluted net income per share of $2.83 TEMPE, Ariz., Feb. 02, 2022 (GLOBE NEWS

TEMPE, Ariz., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2021 financial results on Wednesday, February 2, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss

Achieves 11 Millionth Invisalign Patient MilestoneiTero Scanner Installed-base Reaches 50,000 Units Worldwide Q3 total revenues up 38.4% year-over-year to record $1.016 billion and up 0.5% sequentiallyQ3 diluted net income per share of $2.28; Q3 non-GAAP diluted net income per share of $2.87Q3 operating margin of 25.7%, down 0.9 points sequentially and up 1.6 points year-over-yearQ3 Clear Aligner volume for teens up 26.6% year-over-year to a record 206.0 thousand cases and up 13.8% sequentiallyQ3 Imaging Systems and CAD/CAM Services record revenues of $178.3 million, up 57.3% year-over-year and up 5.0% sequentially TEMPE, Ariz., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc

TEMPE, Ariz., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, announced today that the Company will report third quarter 2021 financial results on Wednesday, October 27, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Company's website at http://investor.aligntech.com. Following the press release, the Company will host a conference

Q2 total revenues up 13.0% sequentially and 186.9% year-over-year to a record $1.0 billionQ2 diluted net income per share of $2.51; Q2 non-GAAP diluted net income per share of $3.04Q2 operating margin of 26.6%, up 1.4 points sequentially and up 47.3 points year-over-yearQ2 Clear Aligner revenues up 11.6% sequentially and 181.9% year-over-year to a record $841.0 millionQ2 Clear Aligner volume up 11.7% sequentially and 200.0% year-over-year to 665.6 thousand casesQ2 Clear Aligner volume for teens up 9.5% sequentially and 156.3% year-over-year to 181.0 thousand casesQ2 Imaging Systems and CAD/CAM Services revenues up 20.0% sequentially and 214.7% year-over-year to a record $169.8 million TEMPE